SCHEMBL6540283

SCHEMBL6540283

CCOC(=O)CC(=O)OC(C(=O)c1ccc(OC)cc1)c1ccc(OC)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.53
KMT2A Q03164 3/20 0.53
NPC1 O15118 3/20 0.53
MEN1 O00255 2/20 0.53
POLB P06746 2/20 0.53
RAB9A P51151 2/20 0.53
NPSR1 Q6W5P4 1/20 0.53
ALDH1A1 P00352 5/20 0.52
TDP1 Q9NUW8 3/20 0.52
GAA P10253 1/20 0.47
ALOX15 P16050 1/20 0.46
HPGD P15428 1/20 0.45
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44
HDAC3 O15379 1/20 0.43
HDAC4 P56524 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC7 Q8WUI4 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3098560 0.89 MAPT (0.58) MAPTKMT2ANPC1MEN1POLB
SCHEMBL12216991 0.83 MEN1 (0.65) MAPTKMT2ANPC1MEN1POLB
SCHEMBL14384221 0.81 MAPT (0.58) MAPTKMT2ANPC1MEN1POLB
SCHEMBL13204575 0.79 POLB (0.55) MAPTKMT2ANPC1MEN1POLB
SCHEMBL31359577 0.77 MAPT (0.64) MAPTKMT2ANPC1MEN1POLB
SCHEMBL314216 0.75 HDAC3 (0.60) MAPTKMT2ANPC1MEN1ALDH1A1
SCHEMBL12240553 0.74 KMT2A (0.68) MAPTKMT2ANPC1MEN1POLB
SCHEMBL12217034 0.74 KMT2A (0.51) MAPTKMT2ANPC1MEN1POLB
SCHEMBL12430380 0.74 ALOX15 (0.55) MAPTKMT2AMEN1RAB9AALDH1A1
SCHEMBL16509661 0.74 ALOX15 (0.55) MAPTKMT2AMEN1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040157891-A1 Inhibitor of cox FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040157891-A1 Inhibitor of cox PTGS1, PTGS2, PTGES2 MAPT 4796/4885KMT2A 3081/4885NPC1 1686/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.